Biomarkers in the diagnosis of pancreatic cancer: Are we closer to finding the golden ticket?Robert O’Neill(UNSW Sydney), Alina Stoita(Creative Research Enterprises (United States))World Journal of GastroenterologyJuly 11, 202110.3748/wjg.v27.i26.4045Cited by 118SaveCiteExport RISWatch citationsRelated PapersImmune activation by DNA damage predicts response to chemotherapy and survival in oesophageal adenocarcinoma|Gut|2019|27